News
DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India
India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential covid-19 vaccine, a senior government official...
News
Serum Institute of India COVID-19 Vaccine advances to trial for phase-III on 1500 Indian patients
Serum institute has completed phase II-B3 trails and will commence phase-III trail after clearances. The third phase trail will be tested on 1500 patients at 14 locations. Balram Bhargava, Director general of the Indian Council of Medical Research, said,...
News
Paradigm4 launches Revels Single Cell app for analysing large-scale data sets
Paradigm4, specialist in scientific data management and scalable computation, has launched its REVEAL: Single CellTM app to offer biopharmaceutical developers the ability to break through the data wrangling and programming challenges associated with the analysis of large-scale, single-cell datasets.
The...
News
Lubrizol Life Science Health awarded grant for generic contraceptive injection research to advance women’s health worldwide
The Lubrizol Corporation has announced that the contract development and manufacturing organization (CDMO) of Lubrizol Life Science Health (LLS Health) has been awarded a grant to support its research on injectable contraceptive formulations designed to bring accessible contraceptive products...
News
Botanical Solution Inc. (BSI) Appoints Marcus Meadows-Smith to their Board
Botanical Solution Inc. (BSI), an innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials (ABM), has appointed Marcus Meadows-Smith to its Board of Directors. As a proven, successful, and recognized leader within the agrochemical industry, Meadows-Smith will...
News
iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201
iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has selected IBIO-201, its LicKM™-ubunit vaccine, as its leading candidate for the prevention of SARS-CoV-2 infection.
iBio previously announced that preclinical immunization studies with IBIO-200 and IBIO-201,...
News
ECCRT and IDDI establish partnership for continuous development of IDDI global team members
European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES provider for Pharmaceutical and Biotechnology companies.
ECCRT will provide access to the eLearning ‘Virtual Campus’...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.